All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Cherie Erkmen, MD
Disclosure(s): AstraZeneca; BMS; Merck; Roche/Genentech: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Pfizer, USA: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Leah Backhus, MD, MPH
Disclosure(s): Astra Zeneca: Consultant (Ongoing); Ethicon: Consultant (Ongoing); Genentech: Consultant (Ongoing)

Presentations

1. The Current Climate in Diversity, Equity, and Inclusion
   Sara Pereira, MD
   Disclosure(s): Edwards Lifesciences: Consultant (Ongoing), Speaker (Ongoing)
    
2. Defining Social Determinants of Health and Why They Matter in Thoracic Surgery
   Fatima G. Wilder, MD, MPH, MSc
    
3. Access to Lung Cancer Screening—Addressing the Barriers to Access
   Loretta Erhunmwunsee, MD
   Disclosure(s): Astrazeneca: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Bristol Myers Squibb Foundation: Advisory Board (Ongoing)
    
4. Impact of Social Determinants in Health Care Delivery—The Volume-Outcome Relationship
   Sidra Bonner, MD MPH MS
    
5. Association of Socioeconomic Disadvantage in Outcomes in Transplantation
   Sara Sakowitz, MS MPH
    
6. A "Vulnerable" Patient-Intensified Protocol to Reduce Coronary Artery Bypass Grafting (CABG) Readmission Disparities: Importance of Social Determinants of Health (SDOH), Insurance, and Race/Ethnicity
   Ralph Mosca, MD, MBA
    
7. Changing Faces in Cardiothoracic Surgery: Match Rates and Demographic Shifts amongst Integrated and Traditional Training Programs
   Michelle Burmistrova, MS
    
8. Panel Discussion / Audience Q&A